Articles

Surprising heart study could bring Lilly $1B annually

Eli Lilly and Co. didn’t win approval for a new drug last week. But its latest study of an existing diabetes drug could create a blockbuster in its own right—adding as much as $1 billion a year to the coffers of the Indianapolis-based drugmaker.

Read More
rop-anthem-062215-2col.jpg

Anthem-Cigna mega deal might snag on Blue Cross

Anthem Inc. has used the Blue Cross and Blue Shield brand names as a powerful tool on its way to becoming the nation’s second-largest health insurer. But those Blue brands now are a hurdle for Anthem’s $54.2 billion acquisition of Cigna Corp.

Read More

Lilly expands R&D outside Indy—again

State and city leaders spend millions each year to entice companies to move here and add jobs here. But for the second time in three months, Eli Lilly and Co. has shown that the biggest attraction to a company is talented workers.

Read More

Anthem to buy Cigna in $54B deal

After a long and stormy courtship, Anthem Inc. announced Friday morning that it will pay $188 per share to acquire Cigna Corp., valuing the deal at $54.2 billion in cash, stock and the assumption of debt.

Read More
rop-rook-072715-2col.jpg

Indy firm joins FBI in race to secure stolen cyber-spying tools

Security analysts and software developers at Rook Security worked with other IT security firms and the FBI’s Indianapolis office to develop a tool that can detect if any of the cyber-spying tools stolen from Italian surveillance firm Hacking Team programs have infected a computer.

Read More